TrialClinical cancer research : an official journal of the American Association for Cancer Research2013

Phase II study of Lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 for metastatic castration-resistant prostate cancer.

Scott T Tagawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.